LYVE-1, the lymphatic system and tumor lymphangiogenesis. by Jackson, D, Prevo, R, Clasper, S, Banerji, S

Rapid plasma membrane-endosomal trafficking of the lymph node sinus and high endothelial venule scavenger receptor/homing receptor stabilin-1 (FEEL-1/CLEVER-1). by Prevo, R, Banerji, S, Ni, J, Jackson, D

Inflammation-induced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1. by Johnson, L, Prevo, R, Clasper, S, Jackson, D

Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. by Prevo, R, Banerji, S, Ferguson, D, Clasper, S, Jackson, D

T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeutics by Herbert, K, Ashton, T, Prevo, R, Pirovano, G, Higgins, G

Overexpression of POLQ confers a poor prognosis in early breast cancer patients. by Higgins, G, Harris, A, Prevo, R, Helleday, T, Mckenna, W, Buffa, F

Distribution of lymphatic vessels in normal and arthritic human synovial tissues. by Xu, H, Edwards, J, Banerji, S, Prevo, R, Jackson, D, Athanasou, N

Targeting ATR in DNA damage response and cancer therapeutics. by Fokas, E, Prevo, R, Hammond, E, Brunner, T, Mckenna, W, Muschel, R

Depletion of Signal Recognition Particle 72kDa increases radiosensitivity by Prevo, R, Tiwana, G, Maughan, T, Buffa, F, McKenna, W, Higgins, G

Targeting ATR in DNA damage response and cancer therapeutics by Fokas, E, Prevo, R, Hammond, E, Brunner, T, McKenna, W, Muschel, R

The distribution of lymphatic vessels in lymphomas compared with reactive lymphadenopathy. by Pillai, G, Roberts, H, Jackson, D, Prevo, R, Pezzella, F, Gatter, K

Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer. by Williams, C, Leek, R, Robson, A, Banerji, S, Prevo, R, Harris, A, Jackson, D

Automated 96-well format high throughput colony formation assay for siRNA library screen by Hatch, SB, Prevo, R, Chan, T, Millar, V, Cornelissen, B, Higgins, G, Ebner, D

Homologous recombination mediates S-phase-dependent radioresistance in cells deficient in DNA polymerase eta. by Nicolay, N, Carter, R, Hatch, S, Schultz, N, Prevo, R, Mckenna, W, Helleday, T, Sharma, R

Targeting TOPK 1 sensitises tumour cells to radiation-induced damage by enhancing replication stress by Herbert, K, Puliyadi, R, Prevo, R, Rodriguez Berriguete, G, Ryan, A, Ramadan, K, Higgins, G

The novel ATR inhibitor VE-821 selectively sensitizes pancreatic cancer cells to radiation and chemotherapy by Fokas, E, Prevo, R, Reaper, P, Charlton, P, Pollard, J, Mckenna, W, Muschel, R, Brunner, T

Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance by Zatreanu, D, Robinson, H, Alkhatib, O, Prevo, R, Higgins, G, Smith, G, Lord, C, Et al

Normal lymphatic development and function in mice deficient for the lymphatic hyaluronan receptor LYVE-1. by Gale, N, Prevo, R, Espinosa, J, Ferguson, D, Dominguez, MG, Yancopoulos, G, Thurston, G, Jackson, D

The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy. by Prevo, R, Fokas, E, Reaper, P, Charlton, P, Pollard, JR, McKenna, W, Muschel, R, Brunner, T

NVP-BEZ235 and NVP-BGT226, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitors, enhance tumor and endothelial cell radiosensitivity. by Fokas, E, Yoshimura, M, Prevo, R, Higgins, G, Hackl, W, Maira, S, Bernhard, E, Mckenna, W, Muschel, R